Results 131 to 140 of about 174,158 (293)
Four empires and an enlargement: States, Societies and individuals: transfiguring perspectives and images of Central and Eastern Europe [PDF]
The relationship between states, societies, and individuals in Central and Eastern Europe has been characterised by periods of change and redefinition. The current political, economic, social and cultural climate necessitates a discussion of these issues,
core
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer +4 more
wiley +1 more source
Addressing HIV stigma in healthcare, community, and legislative settings in Central and Eastern Europe. [PDF]
Schweitzer AM +5 more
europepmc +1 more source
Abstract Aim Mebendazole (MBZ), a benzimidazole anthelmintic with established clinical use, has emerged as a repurposing candidate for primary brain tumours due to its multimodal anticancer actions and central nervous system penetrance. This systematic review synthesizes preclinical and clinical evidence evaluating MBZ's efficacy, mechanisms of action ...
Ciara B. Blum +5 more
wiley +1 more source
The importance of institutions and free trade for economic growth is widely acknowledged in recent economic literature. In this paper we are focused on determining the fractional effects of changes of institutions and trade on economic growth as ...
Katerina Kocevska Shapkova +1 more
doaj
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar +6 more
wiley +1 more source
Aim In the GENESECT study, no significant gemcitabine (GEM) metabolism‐related germline genetic polymorphisms (GPs) were identified because approximately 70% of patients received combination therapy with nab‐paclitaxel, which has metabolic pathways different from GEM.
Takashi Yokokawa +21 more
wiley +1 more source
Genetic continuity, isolation, and gene flow in Stone Age Central and Eastern Europe. [PDF]
Mattila TM +27 more
europepmc +1 more source

